Letters Table 1 Minimum inhibitory concentrations (MIC) of agelasine F. MIC (mg/ml)a agelasine F 3.13 3.13 6.25 3.13 6.25 rifampicin 0.25 0.062>1 0.125 0.125
Planta Med. 66 (2000)
365
M. tuberculosis strain resistant to none (H37RV) (ATCC 27294) isoniazid (ATCC 358222) rifampicin (ATCC 35838) ethambutol (ATCC 35837) ethionamide (ATCC 35830) a
ated. Using the best curve fit, concentrations effecting a 90% (EC90) and 99% (EC99) inhibition of M. tuberculosis growth in MN were determined.
Acknowledgements This work was supported by grants from the International Foundation for Science (GPC), NCDDG collaborative projects, NCI, US NIH (GPC& CMI), UPMSI grants (GPC& LJ
C), Grant No. 11.022, Program in Science& Technology Cooperation, US AID (DH Hillyard and LJC), and the Intra-Agency Agreement Y1A1-5016 from the Division of AIDS, NIAID, US NIH (SGF). Marine samples were collected by PN Aliæo& his group at UPMSI and identified by MK Harper, Scripps Inst. of Oceanography, La Jolla, CA. Mass spectrometry was performed by EM Rachlin, Dept. of Chemistry, Univ. of Utah with funds from the Univ. of Utah and NSF Grant CHE-9002690. Technical assistance at NHDC was provided by A Deming, S Robinson, N Soileau and A Biswas.
Determined in a BACTEC 460 assay system (3).
Materials and Methods The antituberculosis activity in macrophage culture of agelasine F was determined using a modification of the method described in Skinner et al. (8). Murine bone marrow-derived macrophages (MN) were harvested from the femurs of adult BALB/c mice in Dulbecco©s minimal essential medium (DMEM)+ 10% fetal bovine serum (FBS)+ 25 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)+ 2 mM glutamine+ 2.5 g/l NaHCO3 supplemented with 50 mg/ml glutamine and 10% L-929 cell conditioned medium (L-929 CM). Endotoxin content of culture reagents was measured routinely using the Quantitative Chromogenic Limulus Amoebocyte Lysate Assay (Whittaker) and only pyrogen-free disposable glass and plastic ware were used. Bone marrow cells were plated at 1 106/ml on 13 mm LUX cover slips in 24 well tissue culture plates and incubated at 37 8C in 5% CO2. Fresh culture medium was applied every 3 days. After 7± 8 days incubation, BM-MN exhibited the phenotypic characteristics of mature MN and were then placed in culture medium without L-929 CM or antibiotics in preparation for challenge with M. tuberculosis. A frozen suspension of M. tuberculosis Erdman (ATCC 35801), which had previously been passaged through an 8 mm filter to remove clumps, was thawed, sonicated at 50% power for 15 sec in a cup horn sonicator (Ultrasonic, Inc.) to disperse any clumps, and diluted in culture medium. MN monolayers were infected with 1 106 M. tuberculosis in 0.5 ml/well culture medium for 30 min at 37 8C. After removal of extracellular bacilli by washing in PBS, coverslips were transferred to fresh culture medium and incubated 24 h to allow complete phagocytosis of any extracellular organisms adhering to the MN cell surface. Initial levels of M. tuberculosis were approximately 103 bacilli/MN monolayer. Agelasine F was dissolved in DMSO and then diluted 1: 500 in culture medium. Four-fold dilutions were made in culture medium and 1 ml of each concentration was added to MN monolayers in triplicate one day post infection resulting in final concentrations of 0.78, 3.13, 12.5 and 50 mg/ml. Negative control wells received culture medium containing diluted DMSO. Rifampicin served as a positive drug control and was added at final concentrations of 1.2, 0.3, 0.075, and 0.02 mg/ml. After 7 days of incubation at 37 8C in moist 5% CO2 MN were lysed by transferring
the coverslips to a 24 well tissue culture plate containing 0.5 ml/well 0.25% SDS. After 10 min incubation at room temperature, 0.5 ml of RPMI 1640+ 20% FBS was added and the lysates were transferred to a sealed tube, sonicated, serially diluted (10-fold) in RPMI 1640+ 10% FBS and plated on 7H11 agar plates. The plates were incubated at 37 8C in moist 5% CO2 for 18± 21 days, and then CFU were enumer-
References 1
Austin B. A review: Novel pharmaceutical compounds from marine bacteria. Journal of Applied Bacteriology 1989; 67: 461± 70 2 Shen X, Perry TL, Dunbar CD, Kelly-Borges M, Hamann MT. Debromosceptrin, an alkaloid from the Caribbean sponge Agelas conifera. Journal of Natural Products 1998; 61: 1302± 3 3 Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrobial Agents and Chemotherapy 1997; 41: 1004± 9 4 Wu H, Nakamura H, Kobayashi J, Ohizumi Y. Agelasine-E and -F, novel monocyclic diterpenoids with a 9-methyladeninum unit possessing inhibitory effects on Na, K-ATPase isolated from the Okinawan sea sponge Agelas nakamurai Hoshino. Tetrahedron Letters 1984; 25: 3719± 22 5 Capon RJ, Faulkner DJ. Antimicrobial metabolites from a Pacific sponge, Agelas sp. Journal of the American Chemical Society 1984; 106: 1819± 22 6 Nakamura H, Wu H, Kobayashi J, Kobayashi M, Ohizumi Y, Hirata Y. Agelasidines± Novel hypotauracyamine derivatives from the Okinawan sea sponge Agelas nakamurai Hishino. Journal of Organic Chemistry 1985; 50: 2494± 7 7 Cantrell CL, Lu T, Fronczek FR, Fischer NH, Adams LB, Franzblau SG. Antimycobacterial cycloartanes from Borrichia frutescens. Journal of Natural Products 1996; 59: 1131± 6 8 Skinner PS, Furney SK, Jacobs MR, Klopman G, Ellner JJ, Orme IM. A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. Antimicrobial Agents and Chemotherapy 1994; 38: 2557± 63
Gisela P. Concepcion Marine Science Institute University of the Philippines Diliman Quezon City 1101 Philippines E-mail: giselapc@compass.com.ph Fax:+632-921-3799 Tel:+632-433-2990

Mangalindan GC[7 ] 等对从菲律 张兴德 ,等 : 海洋药物研究进展 2 期第 Agelasine F 在体外具有明显的抗结核作用 。Geldof AA [8 ] 等 — 127 — 合成...
Agelasidines A–F (1–6); agelasines B (7), C (10), D (11), and E (12), (–)-2-oxo-agelasine B (8), and (+)-agelasine N (9); ...
(de Nys et al. 1995), brominated indoles from a bryozoan (Kon-Ya et al. 1994), brominated dipeptides and agelasine D from marine sponges (Sjogren ...
Mangalindan GC[7 ] 等对从菲律 http://www.cnki.net 张兴德 ,等 : 海洋药物研究进展 2 期第 Agelasine F 在体外具有明显的抗结核作用 。Geldof AA[8 ] ...
热门文档